Growth Story Still Intact For Protalix BioTherapeutics Inc (PLX)
Protalix BioTherapeutics Inc (PLX) concluded trading on Wednesday at a closing price of $1.40, with 0.4 million shares of worth about $0.56 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -22.22% during that period and on June 18, 2025 the price saw a […]